T N Ngoc1, B Weiss2, L T Trung3. 1. Da Nang Psychiatric Hospital, 193 Nguyen Luong Bang Street, Da Nang, Viet Nam. Electronic address: TranNgoc.DPH@gmail.com. 2. Clinical Sciences Program, Vanderbilt University, 230 Appleton Place, Nashville, TN, 37203, USA. 3. Da Nang Psychiatric Hospital, 193 Nguyen Luong Bang Street, Da Nang, Viet Nam.
Abstract
OBJECTIVE: Although psychoeducation has been found effective for improving the life functioning of patients with schizophrenia in high income countries, there have been relatively few studies of schizophrenia psychoeducation adapted for low and middle-income countries (LMIC), particularly in Southeast Asia. The present study assessed effects of the Family Schizophrenia Psychoeducation Program (FSPP) among Vietnamese patients and their families on the patients' (1) quality of life and (2) medication non-compliance, and the family and patients' (3) stigma towards schizophrenia, and (4) consumer satisfaction. METHOD: This intervention study involved 59 patients, and their families, from the Da Nang Psychiatric Hospital, randomly assigned to treatment (n=30) or control (n=29) conditions. Control subjects received services as usual (antipsychotic medication); treatment group subjects received the FSPP as well. Blind-rater assessments were conducted at T1 immediately after project enrollment (prior to participating in the FSPP) and at T2 six months later. RESULTS: There were significant treatment effects on: (1) quality of life, (2) stigma, (3) medication compliance, and (4) consumer satisfaction, with all effects favoring the treatment group. Effect sizes were moderate to large. CONCLUSIONS: This psychoeducation program appears to reduce stigma, improve quality of life and medication compliance, and increase consumer satisfaction of Vietnamese patients with schizophrenia and their families, beyond the effects of antipsychotic medication. It involves relatively little cost, and it may be useful for it or equivalent programs to be implemented in other hospitals in Viet Nam, and potentially other low-income Asian countries to improve the lives of patients with schizophrenia.
RCT Entities:
OBJECTIVE: Although psychoeducation has been found effective for improving the life functioning of patients with schizophrenia in high income countries, there have been relatively few studies of schizophrenia psychoeducation adapted for low and middle-income countries (LMIC), particularly in Southeast Asia. The present study assessed effects of the Family Schizophrenia Psychoeducation Program (FSPP) among Vietnamese patients and their families on the patients' (1) quality of life and (2) medication non-compliance, and the family and patients' (3) stigma towards schizophrenia, and (4) consumer satisfaction. METHOD: This intervention study involved 59 patients, and their families, from the Da Nang Psychiatric Hospital, randomly assigned to treatment (n=30) or control (n=29) conditions. Control subjects received services as usual (antipsychotic medication); treatment group subjects received the FSPP as well. Blind-rater assessments were conducted at T1 immediately after project enrollment (prior to participating in the FSPP) and at T2 six months later. RESULTS: There were significant treatment effects on: (1) quality of life, (2) stigma, (3) medication compliance, and (4) consumer satisfaction, with all effects favoring the treatment group. Effect sizes were moderate to large. CONCLUSIONS: This psychoeducation program appears to reduce stigma, improve quality of life and medication compliance, and increase consumer satisfaction of Vietnamese patients with schizophrenia and their families, beyond the effects of antipsychotic medication. It involves relatively little cost, and it may be useful for it or equivalent programs to be implemented in other hospitals in Viet Nam, and potentially other low-income Asian countries to improve the lives of patients with schizophrenia.
Authors: I Sibitz; M Amering; A Unger; M E Seyringer; A Bachmann; B Schrank; T Benesch; B Schulze; A Woppmann Journal: Eur Psychiatry Date: 2010-10-30 Impact factor: 5.361
Authors: Richard Schulz; Thomas B Cook; Scott R Beach; Jennifer H Lingler; Lynn M Martire; Joan K Monin; Sara J Czaja Journal: Am J Geriatr Psychiatry Date: 2013-01-02 Impact factor: 4.105
Authors: Sandra Saldivia; Ariadne Runte-Geidel; Pamela Grandón; Francisco Torres-González; Miguel Xavier; Claudio Antonioli; Dinarte A Ballester; Roberto Melipillán; Emiliano Galende; Benjamín Vicente; José Miguel Caldas; Helen Killaspy; Rachel Gibbons; Michael King Journal: BMC Psychiatry Date: 2014-06-18 Impact factor: 3.630
Authors: Sarju Sing Rai; Ruth M H Peters; Elena V Syurina; Irwanto Irwanto; Denise Naniche; Marjolein B M Zweekhorst Journal: Int J Equity Health Date: 2020-11-11